Parker Waichman LLP Headlines by Topic
Aricept
Petition Asks FDA to Pull Aricept High Dose Version from the Market
May 19, 2011
| Parker Waichman LLP
A leading consumer advocacy group says the highest dose of the Alzheimer's treatment Aricept (donepezil) is dangerous and ineffective, and should be...
Dementia Drugs May be Risky
May 28, 2009
| Parker Waichman LLP
We have long been writing about the serious side effects associated with some popular dementia drugs. Now, ScienceDaily is reporting that these...
Aricept, Zantac, Detrol, other Anticholinergic Drugs Lined to Mental Impairment in Elderly
May 6, 2008
| Parker Waichman LLP
Two separate reports written by researchers at Wake Forest University School of Medicine support findings released recently concerning...
Eleven Deaths during ARICEPT Trial Raises Concern over FDA Application to Permit Wider Use of the Drug
Mar 20, 2006
| Newsinferno News Staff
An article in the October, 2005, issue of Worst Pills Best Pills Newsletter from the consumer watchdog group, Public Citizen, reported that three...
Company reports 11 deaths in Aricept study
Mar 18, 2006
| Newsday
Eleven patients have died while taking the Alzheimer's drug Aricept in a clinical trial testing the drug as a treatment for vascular dementia, a...
Page 1/1
